nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXA2R—hematopoietic system—hematologic cancer	0.048	0.153	CbGeAlD
Ridogrel—TBXAS1—hematopoietic system—hematologic cancer	0.0421	0.134	CbGeAlD
Ridogrel—TBXA2R—blood—hematologic cancer	0.0318	0.101	CbGeAlD
Ridogrel—TBXAS1—blood—hematologic cancer	0.0279	0.0888	CbGeAlD
Ridogrel—TBXA2R—lung—hematologic cancer	0.0279	0.0887	CbGeAlD
Ridogrel—TBXAS1—bone marrow—hematologic cancer	0.027	0.0859	CbGeAlD
Ridogrel—TBXA2R—testis—hematologic cancer	0.0263	0.0837	CbGeAlD
Ridogrel—TBXAS1—lung—hematologic cancer	0.0245	0.0778	CbGeAlD
Ridogrel—TBXAS1—testis—hematologic cancer	0.0231	0.0735	CbGeAlD
Ridogrel—TBXA2R—lymph node—hematologic cancer	0.0191	0.0606	CbGeAlD
Ridogrel—TBXAS1—lymph node—hematologic cancer	0.0167	0.0532	CbGeAlD
Ridogrel—TBXA2R—Signaling Pathways—ARHGEF12—hematologic cancer	0.000527	0.000768	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ADCY7—hematologic cancer	0.000526	0.000768	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTHLH—hematologic cancer	0.000524	0.000765	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—JAK1—hematologic cancer	0.000516	0.000753	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PRKCG—hematologic cancer	0.000516	0.000753	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—UGT1A1—hematologic cancer	0.000516	0.000752	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ARHGEF1—hematologic cancer	0.000513	0.000749	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTGER4—hematologic cancer	0.00051	0.000744	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CRABP1—hematologic cancer	0.000502	0.000732	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC22A1—hematologic cancer	0.000502	0.000732	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ALOX5—hematologic cancer	0.000489	0.000713	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IL2RA—hematologic cancer	0.000482	0.000703	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL3—hematologic cancer	0.000481	0.000702	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—SRC—hematologic cancer	0.000478	0.000697	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTHLH—hematologic cancer	0.000476	0.000694	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NUP98—hematologic cancer	0.000474	0.000691	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—hematologic cancer	0.00047	0.000686	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	0.000466	0.000679	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PDGFB—hematologic cancer	0.000465	0.000678	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTGER4—hematologic cancer	0.000463	0.000676	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL17—hematologic cancer	0.00046	0.000671	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGRN—hematologic cancer	0.00046	0.000671	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ADCY7—hematologic cancer	0.00046	0.000671	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOA3—hematologic cancer	0.00046	0.000671	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NUP214—hematologic cancer	0.000457	0.000666	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCR5—hematologic cancer	0.000452	0.000659	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.000452	0.000659	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CDK2—hematologic cancer	0.000451	0.000658	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCR4—hematologic cancer	0.000451	0.000658	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	0.00045	0.000657	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ABCG2—hematologic cancer	0.000447	0.000652	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTR—hematologic cancer	0.000447	0.000652	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LEF1—hematologic cancer	0.000444	0.000647	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	0.000441	0.000643	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ENO2—hematologic cancer	0.000439	0.00064	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GNA13—hematologic cancer	0.000436	0.000637	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL3—hematologic cancer	0.000435	0.000634	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MAPK14—hematologic cancer	0.000433	0.000631	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TIAM1—hematologic cancer	0.000429	0.000626	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	0.000427	0.000623	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTT1—hematologic cancer	0.000425	0.000621	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—RASGRP1—hematologic cancer	0.00042	0.000613	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—FN1—hematologic cancer	0.000419	0.000612	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000419	0.000611	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCL2—hematologic cancer	0.000418	0.00061	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAK3—hematologic cancer	0.000416	0.000607	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SDC1—hematologic cancer	0.000416	0.000607	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—PIK3CA—hematologic cancer	0.000416	0.000606	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCR4—hematologic cancer	0.000409	0.000597	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	0.000405	0.00059	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CG—hematologic cancer	0.000401	0.000585	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCR7—hematologic cancer	0.000399	0.000582	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL13—hematologic cancer	0.000399	0.000582	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000397	0.000579	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL3—hematologic cancer	0.000395	0.000576	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PTPN11—hematologic cancer	0.000394	0.000575	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NCOR2—hematologic cancer	0.000394	0.000575	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000392	0.000572	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL3RA—hematologic cancer	0.000389	0.000567	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CRKL—hematologic cancer	0.000389	0.000567	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—RASGRP1—hematologic cancer	0.000382	0.000557	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GRB2—hematologic cancer	0.000378	0.000551	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RGS2—hematologic cancer	0.000375	0.000547	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.000375	0.000547	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CREBBP—hematologic cancer	0.000372	0.000543	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	0.000372	0.000542	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CMA1—hematologic cancer	0.000371	0.000541	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TRH—hematologic cancer	0.000371	0.000541	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TRIO—hematologic cancer	0.000371	0.000541	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	0.000364	0.000531	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGO2—hematologic cancer	0.000363	0.00053	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SPHK1—hematologic cancer	0.000363	0.00053	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LPAR1—hematologic cancer	0.000359	0.000524	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HDAC9—hematologic cancer	0.000359	0.000524	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—H3F3B—hematologic cancer	0.000356	0.000519	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CD44—hematologic cancer	0.000354	0.000516	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NQO1—hematologic cancer	0.000354	0.000516	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CD—hematologic cancer	0.000353	0.000515	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ALB—hematologic cancer	0.000348	0.000508	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.000346	0.000505	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	0.000344	0.000502	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GRB2—hematologic cancer	0.000343	0.000501	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CSF2—hematologic cancer	0.000338	0.000493	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYCS—hematologic cancer	0.000335	0.000488	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3R1—hematologic cancer	0.000333	0.000486	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HSP90AA1—hematologic cancer	0.000332	0.000485	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDE4B—hematologic cancer	0.000331	0.000482	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CNR2—hematologic cancer	0.000331	0.000482	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	0.000329	0.00048	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF19—hematologic cancer	0.000328	0.000478	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—JAK1—hematologic cancer	0.000326	0.000476	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PRKCG—hematologic cancer	0.000326	0.000476	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RAC2—hematologic cancer	0.000325	0.000475	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—JAK2—hematologic cancer	0.000324	0.000472	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—DKK1—hematologic cancer	0.000323	0.000471	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT5B—hematologic cancer	0.00032	0.000467	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ADCY7—hematologic cancer	0.000311	0.000454	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CB—hematologic cancer	0.000308	0.000449	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CSF2—hematologic cancer	0.000307	0.000447	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL2RA—hematologic cancer	0.000305	0.000444	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—XIAP—hematologic cancer	0.000303	0.000441	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000299	0.000436	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	0.000297	0.000433	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PRKCG—hematologic cancer	0.000296	0.000432	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—JAK1—hematologic cancer	0.000296	0.000432	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTP1—hematologic cancer	0.000295	0.00043	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SMARCA4—hematologic cancer	0.000295	0.00043	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SH2B3—hematologic cancer	0.000295	0.00043	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GZMB—hematologic cancer	0.000293	0.000427	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CTNNA1—hematologic cancer	0.000286	0.000417	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000285	0.000416	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HSPB1—hematologic cancer	0.000284	0.000415	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL3—hematologic cancer	0.000284	0.000415	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000284	0.000415	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IL2—hematologic cancer	0.000282	0.000412	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTHLH—hematologic cancer	0.000281	0.00041	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SDC1—hematologic cancer	0.000281	0.00041	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ABCB1—hematologic cancer	0.000279	0.000407	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL2RA—hematologic cancer	0.000277	0.000403	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTGER4—hematologic cancer	0.000274	0.000399	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LCK—hematologic cancer	0.000272	0.000397	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTM1—hematologic cancer	0.000271	0.000395	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOR1—hematologic cancer	0.000271	0.000395	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—H3F3A—hematologic cancer	0.000267	0.000389	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRKCZ—hematologic cancer	0.00026	0.000379	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000254	0.00037	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—EP300—hematologic cancer	0.000253	0.00037	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PARP1—hematologic cancer	0.000251	0.000366	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FBXW7—hematologic cancer	0.000247	0.00036	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SRC—hematologic cancer	0.000246	0.00036	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCR4—hematologic cancer	0.000242	0.000353	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HDAC2—hematologic cancer	0.000242	0.000353	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VEGFA—hematologic cancer	0.00024	0.00035	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTHFR—hematologic cancer	0.00024	0.000349	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NRAS—hematologic cancer	0.000237	0.000346	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CBL—hematologic cancer	0.000236	0.000344	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL3—hematologic cancer	0.000233	0.00034	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CG—hematologic cancer	0.00023	0.000336	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTPN1—hematologic cancer	0.000229	0.000334	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MAPK3—hematologic cancer	0.000227	0.000331	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTPN11—hematologic cancer	0.000226	0.00033	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RASGRP1—hematologic cancer	0.000226	0.000329	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SYK—hematologic cancer	0.000225	0.000328	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HSP90AA1—hematologic cancer	0.000225	0.000328	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000223	0.000325	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—hematologic cancer	0.00022	0.000321	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CREB1—hematologic cancer	0.000219	0.00032	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT1—hematologic cancer	0.000217	0.000316	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL2—hematologic cancer	0.000215	0.000313	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6R—hematologic cancer	0.000214	0.000312	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.000211	0.000308	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000211	0.000307	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—JAK2—hematologic cancer	0.000205	0.000299	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—KRAS—hematologic cancer	0.000204	0.000298	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MAP2K1—hematologic cancer	0.000204	0.000297	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GRB2—hematologic cancer	0.000203	0.000296	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CD—hematologic cancer	0.000203	0.000295	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDGFA—hematologic cancer	0.000202	0.000295	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CG—hematologic cancer	0.000201	0.000294	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KITLG—hematologic cancer	0.000199	0.000291	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT5A—hematologic cancer	0.000195	0.000284	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000194	0.000284	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN2B—hematologic cancer	0.000193	0.000282	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3R1—hematologic cancer	0.000191	0.000279	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CA—hematologic cancer	0.000188	0.000273	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CD86—hematologic cancer	0.000187	0.000273	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CREBBP—hematologic cancer	0.000187	0.000272	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—JAK2—hematologic cancer	0.000186	0.000271	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HES1—hematologic cancer	0.000184	0.000269	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NCOR1—hematologic cancer	0.000183	0.000267	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TP53—hematologic cancer	0.000181	0.000265	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CSF2—hematologic cancer	0.000181	0.000264	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF1—hematologic cancer	0.000181	0.000264	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FOXO1—hematologic cancer	0.000179	0.000261	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL2—hematologic cancer	0.000179	0.00026	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDGFRB—hematologic cancer	0.000178	0.00026	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CD—hematologic cancer	0.000177	0.000258	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CB—hematologic cancer	0.000177	0.000257	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDGFRA—hematologic cancer	0.000176	0.000256	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAK1—hematologic cancer	0.000175	0.000255	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRKCG—hematologic cancer	0.000175	0.000255	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ALB—hematologic cancer	0.000175	0.000255	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—HRAS—hematologic cancer	0.000173	0.000253	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3R1—hematologic cancer	0.000167	0.000244	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL2RA—hematologic cancer	0.000163	0.000238	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL2—hematologic cancer	0.000162	0.000236	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TERT—hematologic cancer	0.000162	0.000236	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDGFB—hematologic cancer	0.000158	0.00023	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CB—hematologic cancer	0.000154	0.000225	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TSC2—hematologic cancer	0.000154	0.000225	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—AKT1—hematologic cancer	0.000153	0.000223	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGFR3—hematologic cancer	0.000148	0.000216	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAPK14—hematologic cancer	0.000147	0.000214	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ESR1—hematologic cancer	0.000144	0.00021	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FN1—hematologic cancer	0.000142	0.000207	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—BAD—hematologic cancer	0.000141	0.000205	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NFKBIA—hematologic cancer	0.000141	0.000205	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH1—hematologic cancer	0.000139	0.000203	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CD80—hematologic cancer	0.000136	0.000199	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CG—hematologic cancer	0.000136	0.000198	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KIT—hematologic cancer	0.000136	0.000198	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—NRAS—hematologic cancer	0.000136	0.000198	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTPN11—hematologic cancer	0.000134	0.000195	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTEN—hematologic cancer	0.000133	0.000194	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MAPK3—hematologic cancer	0.00013	0.00019	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CREB1—hematologic cancer	0.00013	0.000189	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—BRAF—hematologic cancer	0.000128	0.000187	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—EP300—hematologic cancer	0.000127	0.000185	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL2—hematologic cancer	0.000127	0.000185	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6R—hematologic cancer	0.000126	0.000184	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CREBBP—hematologic cancer	0.000126	0.000184	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAP2K1—hematologic cancer	0.00012	0.000176	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CD—hematologic cancer	0.00012	0.000174	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000119	0.000173	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—KRAS—hematologic cancer	0.000117	0.000171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF2—hematologic cancer	0.000115	0.000167	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3R1—hematologic cancer	0.000113	0.000165	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAK2—hematologic cancer	0.00011	0.00016	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CA—hematologic cancer	0.000108	0.000157	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MDM2—hematologic cancer	0.000107	0.000156	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CB—hematologic cancer	0.000104	0.000152	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MTOR—hematologic cancer	0.000104	0.000152	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—HRAS—hematologic cancer	9.96e-05	0.000145	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1B—hematologic cancer	9.79e-05	0.000143	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AKT1—hematologic cancer	9.68e-05	0.000141	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CASP3—hematologic cancer	9.59e-05	0.00014	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL2—hematologic cancer	9.58e-05	0.00014	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6—hematologic cancer	9.53e-05	0.000139	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CA—hematologic cancer	9.4e-05	0.000137	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCND1—hematologic cancer	9.34e-05	0.000136	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JUN—hematologic cancer	9.32e-05	0.000136	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1A—hematologic cancer	9.03e-05	0.000132	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTEN—hematologic cancer	9.01e-05	0.000131	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAPK8—hematologic cancer	8.82e-05	0.000129	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AKT1—hematologic cancer	8.79e-05	0.000128	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EP300—hematologic cancer	8.59e-05	0.000125	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SRC—hematologic cancer	8.36e-05	0.000122	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VEGFA—hematologic cancer	8.14e-05	0.000119	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT3—hematologic cancer	8.06e-05	0.000118	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NRAS—hematologic cancer	8.04e-05	0.000117	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAPK3—hematologic cancer	7.7e-05	0.000112	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKT1—hematologic cancer	7.68e-05	0.000112	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MYC—hematologic cancer	7.49e-05	0.000109	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—hematologic cancer	7.47e-05	0.000109	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KRAS—hematologic cancer	6.92e-05	0.000101	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CA—hematologic cancer	6.36e-05	9.27e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TP53—hematologic cancer	6.15e-05	8.97e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HRAS—hematologic cancer	5.88e-05	8.58e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6—hematologic cancer	5.63e-05	8.21e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKT1—hematologic cancer	5.19e-05	7.57e-05	CbGpPWpGaD
